Amedeo Lonardo

Active 1996–2026

123
Papers
19,118
Citations
68
h-index
111
i10-index

Citations

Citations per year for Amedeo Lonardo1991: 1 citations1998: 2 citations1999: 3 citations2000: 1 citations2001: 6 citations2002: 13 citations2003: 7 citations2004: 13 citations2005: 44 citations2006: 33 citations2007: 37 citations2008: 30 citations2009: 48 citations2010: 46 citations2011: 42 citations2012: 49 citations2013: 75 citations2014: 111 citations2015: 144 citations2016: 160 citations2017: 241 citations2018: 175 citations2019: 735 citations2020: 919 citations2021: 1,174 citations2022: 954 citations2023: 680 citations2024: 1,125 citations2025: 687 citations2026: 32 citations1992–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,496 citing papers, 17.2% of this breakdownChina: 1,226 citing papers, 14.1% of this breakdownItaly: 814 citing papers, 9.4% of this breakdownUnited Kingdom: 517 citing papers, 5.9% of this breakdownGermany: 300 citing papers, 3.5% of this breakdownSouth Korea: 259 citing papers, 3% of this breakdownSpain: 255 citing papers, 2.9% of this breakdownCanada: 221 citing papers, 2.5% of this breakdownJapan: 209 citing papers, 2.4% of this breakdownAustralia: 201 citing papers, 2.3% of this breakdownFrance: 196 citing papers, 2.3% of this breakdownIndia: 166 citing papers, 1.9% of this breakdown
0%17.2%Other 32.6%

Fields

  • Medicine84.6%
  • Biochemistry, Genetics and Molecular Biology8.2%
  • Immunology and Microbiology1.3%
  • Neuroscience0.9%
  • Nursing0.7%
  • Agricultural and Biological Sciences0.7%
  • Other3.6%

Topics

  • Liver Disease Diagnosis and Treatment22.9%
  • Diet, Metabolism, and Disease6.6%
  • Liver Disease and Transplantation5.1%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4.8%
  • Alcohol Consumption and Health Effects3.4%
  • Hepatitis C virus research2%
  • Other55.2%

Coauthors

All papers

Open in search
  1. Sex and gender: modifiers of health, disease, and medicine

    Authors: , , , , , , , , , , , , , , , , , - The Lancet 2020 cited by 1,989

  2. Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps

    Authors: , , , , , , , - Hepatology 2019 cited by 1,052

  3. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

    Authors: , , , , - Journal of Hepatology 2016 cited by 1,410

  4. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?

    Authors: , , , - Journal of Hepatology 2017 cited by 736

  5. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis

    Authors: , , , , , , , , - Gut 2020 cited by 376

  6. Global burden of metabolic diseases, 1990–2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leon A. Adams, Said A. Al‐Busafi, Ala I. Sharara, Wah‐Kheong Chan, Syed Imran Abbas, Silvia Sookoian, Sombat Treeprasertsuk, Ponsiano Ocama, Khalid Alswat, Alice P.S. Kong, Karim Ataya, Michelle Ching Lim-Loo, Rodolfo J. Oviedo, Olivia Szepietowski, Yasser Fouad, Huijie Zhang, Tamer N Abdelbaki, Christos S. Katsouras, Arun Prasad, Omar Thaher, Arshad Ali, Gabriel A Molina, Ki‐Chul Sung, Qin‐Fen Chen, Cosmas Rinaldi Adithya Lesmana, Ming‐Hua Zheng - Metabolism 2024 cited by 302

  7. Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials

    Authors: , , , , , - Metabolites 2021 cited by 295

  8. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk

    Authors: , , , , , - Advances in Therapy 2017 cited by 555

  9. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis

    Authors: , , , , , , , , - Journal of Gastroenterology and Hepatology 2015 cited by 724

  10. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yasser Fouad, Christos S. Mantzoros, Huijie Zhang, Nahúm Méndez‐Sánchez, Silvia Sookoian, Wah‐Kheong Chan, Sombat Treeprasertsuk, Leon A. Adams, Ponsiano Ocama, John Ryan, Nilanka Perera, Ala I. Sharara, Said A. Al‐Busafi, Christopher Opio, Manuel Garcia, Michelle Ching Lim-Loo, Elena Ruiz‐Úcar, Arun Prasad, Anna Casajoana, Tamer N. Abdelbaki, Ming‐Hua Zheng - EClinicalMedicine 2024 cited by 191

  11. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus

    Authors: , , - Nature Reviews Endocrinology 2017 cited by 397

  12. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes

    Authors: , , , , , , , , , , , , - Journal of Gastroenterology and Hepatology 2009 cited by 629

  13. Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature

    Authors: , , , , , , , , , , , , , , - Journal of Hepatology 2024 cited by 33

  14. Clinical features and long-term outcomes of patients diagnosed with MASLD, MAFLD, or both

    Authors: , , , , - Journal of Hepatology 2024 cited by 40

  15. Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research

    Authors: , - Journal of Clinical Medicine 2020 cited by 129

  16. Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

    Authors: , , , , , , - Thyroid 2018 cited by 152

  17. Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications

    Authors: , , , - International Journal of Molecular Sciences 2022 cited by 65

  18. Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation

    Authors: , , , , , - Nature Reviews Endocrinology 2022 cited by 63

  19. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis

    Authors: , , , , , , - Metabolism 2017 cited by 358

  20. History of Nonalcoholic Fatty Liver Disease

    Authors: , , , - International Journal of Molecular Sciences 2020 cited by 140

  21. Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction

    Authors: , , , - Metabolism and Target Organ Damage 2022 cited by 48

  22. Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome

    Authors: , , , , - Digestive and Liver Disease 2014 cited by 698

  23. Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers

    Authors: , , , - Metabolism 2024 cited by 43

  24. Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management

    Authors: , , - Advances in Therapy 2021 cited by 92